Table 3.
Percentage of variation (%) in the immunolabelling of the interfollicular scalp in males (M) and females (F), older (O) or younger (Y).
| Tissue/antigen | Gender effect | Age effect | Alopecia impact | ||
|---|---|---|---|---|---|
| M versus F (%) | OM versus YM (%) | OF versus YF (%) | Alopecia versus hair fullness | ||
| YM (%) | YF (%) | ||||
| Reticular dermis | |||||
| Lysozyme | 305* | 74* | 571* | 0 | 134* |
| Vimentin | 193* | −19* | 0 | −30 | 0 |
| Factor XIIIa | 11* | 19* | 0 | −7 | 5 |
| Versican | 0 | 0 | −20* | 22* | 0 |
| Ulex europaeus agglutinin | −14* | −25* | −17* | 0 |
−16* |
| Podoplanin | −25* | 0 | 0 | 30* | 0 |
| CD117 | −25* | 9* | −17* | 0 | 0 |
| Epidermis | |||||
| CD44 variant 3 | 19* | −30* | −21* | −22* | 0 |
| Ki67 | 0 | −22* | −19* | 0 | −9* |
*P < 0.001.